| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/25/2009 | US20090163462 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 06/25/2009 | US20090163460 Diagnostics and therapeutics for early-onset menopause |
| 06/25/2009 | US20090163456 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 06/25/2009 | US20090163451 Methods for treating visceral pain |
| 06/25/2009 | US20090163441 Hyaluronic Acid Binary Mixtures and Therapeutic Use Thereof |
| 06/25/2009 | US20090162448 Metal Carbonate Particles and Methods of Making Thereof |
| 06/25/2009 | US20090162421 Drugs as well as their production and use in the treatment of pain-associated neuropathies |
| 06/25/2009 | US20090162386 Chondrocyte therapeutic delivery system |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162333 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases |
| 06/25/2009 | DE3943838B4 Kompositionen zur topischen Anwendung enthaltend Cyclosporine Compositions for topical application containing Cyclosporine |
| 06/25/2009 | DE102007062550A1 Perhydrochinoxalin-Derivate Perhydroquinoxaline derivatives |
| 06/25/2009 | CA2709821A1 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 06/25/2009 | CA2708854A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | CA2708361A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 06/25/2009 | CA2708228A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | CA2707422A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | CA2706839A1 Aminotriazole derivatives as alx agonists |
| 06/24/2009 | EP2072509A1 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents |
| 06/24/2009 | EP2072082A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent |
| 06/24/2009 | EP1954698B1 Spirocyclic compounds as hdac inhibitors |
| 06/24/2009 | EP1951261A4 Compositions and methods for treating inflammatory disorders |
| 06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | EP1152761B1 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503598C Improved chemical process and pharmaceutical formulation |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503567C Method for preparing-4-bromine-7-methyl isatin |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/24/2009 | CN100502911C An anti-rheumatism medicament and preparation method thereof |
| 06/24/2009 | CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/24/2009 | CN100502883C Cornel extract oral medicine compositions of low irritation to gastrointestinal tract and its preparation |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/24/2009 | CN100502852C Flurbiprofenbab preparation and its preparation method |
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550497 sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550480 1,8-naphthyridin-2(1H)-ones; treating CSBP/p38 kinase mediated diseases; cytokine suppressive anti-inflammatory drugs |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
| 06/23/2009 | CA2373611C Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
| 06/23/2009 | CA2214131C Trisubstituted phenyl derivatives |
| 06/18/2009 | WO2009076602A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076571A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076105A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 06/18/2009 | WO2009075826A1 Methods for increasing white blood cells |
| 06/18/2009 | WO2009075822A1 Methods for inhibiting t helper cell differentiation |
| 06/18/2009 | WO2009075583A1 Use of particles comprising an alcohol |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009075094A1 Tape preparation comprising etodolac in ionic liquid form |
| 06/18/2009 | WO2009074809A1 Sigma ligands and ikk / nf - kb inhibitors for medical treatment |
| 06/18/2009 | WO2009074794A2 Anti-inflammatory compositions and combinations |
| 06/18/2009 | WO2009074644A1 Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/18/2009 | WO2009074594A1 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 06/18/2009 | WO2009074593A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 06/18/2009 | WO2009074592A1 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 06/18/2009 | WO2009074591A1 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 06/18/2009 | WO2009074590A1 N- (2 { [1-phenyl-1h-indaz0l-4-yl] amino} propyl) -sulfonamide derivatives as non-steroidal glucocorticoid receptor ligands for the treatment of inflammations |
| 06/18/2009 | WO2009074519A1 Combinations of pyrazolyl or isoxazolyl p2x7 modulators with further therapeutic agents |
| 06/18/2009 | WO2009074518A1 Combinations of prolinamide p2x7 modulators with further therapeutic agents |
| 06/18/2009 | WO2009074157A1 Fully-modified phenyl pyrrole aminoguanidines |
| 06/18/2009 | WO2009073931A1 Nutraceutical composition and methods of use |
| 06/18/2009 | WO2009073930A1 Nutraceutical composition and methods of use |
| 06/18/2009 | WO2009036996A3 Small molecule bradykinin b1 receptor antagonists |
| 06/18/2009 | WO2008057855A9 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
| 06/18/2009 | US20090156803 Condensed furan compounds |
| 06/18/2009 | US20090156678 Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides |
| 06/18/2009 | US20090156670 Nonaqueous liquid parenteral aceclofenac formulation |
| 06/18/2009 | US20090156666 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/18/2009 | US20090156656 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity |
| 06/18/2009 | US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 06/18/2009 | US20090156641 Inhibition of cyclooxygenase-2 activity |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156601 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 2-(3-hydroxyphenyl)-4-(morpholin-4-yl)-6-(pyridin-3-ylmethylamino) pyrimidine |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
| 06/18/2009 | US20090156588 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders |
| 06/18/2009 | US20090156557 Kinase inhibitors |
| 06/18/2009 | US20090156555 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 06/18/2009 | US20090156551 Novel composition |